NCT03178422View on ClinicalTrials.gov

Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

October 18, 2017

Study Completion Date

October 31, 2017

Conditions
Smoking Cessation
Interventions
DRUG

CQSS2

Nicotine Replacement Therapy

DRUG

NicoDerm CQ Patch

Nicotine Replacement Therapy

Trial Locations (5)

14609

Rochester Clinical Research, Inc., Rochester

36608

Coastal Clinical Research, Inc., Mobile

40509

Central Kentucky Research Associates, LLC, Lexington

64114

Center for Pharmaceutical Research, LLC, Kansas City

85283

Clinical Research Consortium, Tempe

Sponsors
All Listed Sponsors
lead

Chrono Therapeutics, Inc.

INDUSTRY